Cargando…

Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

To evaluate whether preventive treatment can modify endothelial and oxidative biomarkers of vascular disease risk in patients with high-frequency episodic and chronic migraine. In this observational, prospective pilot study, 88 prophylactic treatment-naïve patients with episodic and chronic migraine...

Descripción completa

Detalles Bibliográficos
Autores principales:	González Mingot, Cristina, Santos Lasaosa, Sonia, Colàs Campàs, Laura, Chilangua Canaval, Laura, Gil Sánchez, Anna, Brieva Ruiz, Luis, Marzo Alonso, María Cristina, Peralta Moncusi, Silvia, Valls Marsal, Joan, Cambray Carner, Serafí, Purroy García, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632400/ https://www.ncbi.nlm.nih.gov/pubmed/37940678 http://dx.doi.org/10.1038/s41598-023-44522-8

Ejemplares similares

Preventive treatment can reverse cognitive impairment in chronic migraine
por: González-Mingot, Cristina, et al.
Publicado: (2022)

Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients()
por: Purroy, Francisco, et al.
Publicado: (2016)

Consensus of the Brazilian Headache Society (SBCe) for the Prophylactic Treatment of Episodic Migraine: part I
por: Melhado, Eliana Meire, et al.
Publicado: (2022)

Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II
por: Santos, Paulo Sergio Faro, et al.
Publicado: (2022)

Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière’s disease or migraine-associated vertigo?
por: TEGGI, R., et al.
Publicado: (2010)

Prophylactic treatment of vestibular migraine()
por: Salmito, Márcio Cavalcante, et al.
Publicado: (2016)

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
por: Sancho-Saldaña, Agustín, et al.
Publicado: (2022)

Advances in topiramate as prophylactic treatment for migraine
por: Hu, Chuan, et al.
Publicado: (2021)

Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort
por: Valls, Joan, et al.
Publicado: (2019)

Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
por: Papetti, Laura, et al.
Publicado: (2019)

Defining the Differences Between Episodic Migraine and Chronic Migraine
por: Katsarava, Zaza, et al.
Publicado: (2011)

Pediatric migraine and episodic syndromes that may be associated with migraine
por: Spiri, Daniele, et al.
Publicado: (2014)

Interventional Procedures in Episodic Migraine
por: Plato, Brian M., et al.
Publicado: (2020)

Episodic Migraine and Older Adults
por: Riggins, Nina, et al.
Publicado: (2022)

Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
por: Cambray, Serafi, et al.
Publicado: (2020)

The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
por: Ramos-Araque, Maria E., et al.
Publicado: (2018)

A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
por: Torres, Pascual, et al.
Publicado: (2023)

Sleep changes during prophylactic treatment of migraine
por: Duman, Taşkın, et al.
Publicado: (2015)

Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine
por: Shaik, Munvar Miya, et al.
Publicado: (2015)

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
por: Vandervorst, Fenne, et al.
Publicado: (2021)

Oral Chinese Herbal Medicine as Prophylactic Treatment for Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Lyu, Shaohua, et al.
Publicado: (2020)

Migraine with benign episodic unilateral mydriasis
por: Skeik, Nedaa, et al.
Publicado: (2011)

The acute and preventative treatment of episodic migraine
por: Miller, Sarah
Publicado: (2012)

Atogepant for the prevention of episodic migraine in adults
por: Switzer, Maranda Paige, et al.
Publicado: (2022)

Sex and Gender Considerations in Episodic Migraine
por: Ahmad, Sarah R., et al.
Publicado: (2022)

Optimizing prophylactic treatment of migraine: Subtypes and patient matching
por: Dib, Michel
Publicado: (2008)

Autonomous control of cardiovascular reactivity in patients with episodic and chronic forms of migraine
por: Mamontov, Oleg V., et al.
Publicado: (2016)

Inflammatory Response of Ischemic Tolerance in Circulating Plasma: Preconditioning-Induced by Transient Ischemic Attack (TIA) Phenomena in Acute Ischemia Patients (AIS)
por: Colàs-Campàs, Laura, et al.
Publicado: (2020)

The borderland of migraine with aura: episodic unilateral mydriasis
por: Maggioni, F., et al.
Publicado: (2010)

Cerebral neurocysticercosis mimicking or comorbid with episodic migraine?
por: Fogang, Yannick Fogoum, et al.
Publicado: (2014)

Depression and risk of transformation of episodic to chronic migraine
por: Ashina, Sait, et al.
Publicado: (2012)

Alterations in pain processing circuitries in episodic migraine
por: Mungoven, Tiffani J., et al.
Publicado: (2022)

Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
por: Root, Shane, et al.
Publicado: (2023)

Prophylactic treatment of migraine; the patient's view, a qualitative study
por: Dekker, Frans, et al.
Publicado: (2012)

Prophylactic treatments of migraine and GPs in the north of France: evaluation of practices
por: Christian, CL
Publicado: (2013)

Application and efficacy of levetiracetam in prophylactic treatment of migraine without aura
por: Maykova, TN
Publicado: (2013)

Evaluation of body composition in patients with migraine on prophylactic treatment with topiramate
por: Caverni, Camila Naegeli, et al.
Publicado: (2021)

Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease
por: Forné, Carles, et al.
Publicado: (2019)

P043. Hyperechogenicity of the periaqueductal gray in chronic migraine and episodic migraine as a potential marker of progressive dysfunction: preliminary results with transcranial sonography
por: Guaschino, Elena, et al.
Publicado: (2015)

Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
por: González-Mingot, Cristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sus7204k0h51tcoscal9mvrdf8